The Patent Finder

Ribomic Inc.

Also on record
Records under this name other than the patents Ribomic Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Showing 1 to 10 of 10 · Back to Ribomic Inc.

PatentTitleStatus Expires Confidence
US 8,128,934Method for Treatment or Prevention of Disease Associated with Functional Disorder of Regulatory T Cell
Formerly held
Term ended
Term ended Nov 14, 2026 · High confidence
Term endedTerm ended Nov 14, 2026High confidence
US 8,637,656Nucleic acid capable of binding to immunoglobulin G and use thereof
Lapsed on the fee record
Ended Jan 28, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jan 28, 2026From the USPTO record
US 9,567,589NGF aptamer and application thereof
Lapsed on the fee record
Ended Feb 14, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 14, 2025From the USPTO record
US 9,175,292Aptamer for NGF and Use Thereof
Lapsed on the fee record
Ended Nov 3, 2023 · High confidence
Lapsed on the fee recordEnded Nov 3, 2023High confidence
US 10,260,070Aptamer for NGF and Use Thereof
Lapsed on the fee record
Ended Apr 16, 2023 · High confidence
Lapsed on the fee recordEnded Apr 16, 2023High confidence
US 9,506,070Aptamer Against Midkine and Applications Thereof
Formerly held
Lapsed on the fee record
Ended Nov 29, 2020 · High confidence
Lapsed on the fee recordEnded Nov 29, 2020High confidence
US 8,080,649Aptamer against midkine and use thereof
Lapsed on the fee record
Ended Dec 20, 2019 · From the USPTO record
Lapsed on the fee recordEnded Dec 20, 2019From the USPTO record
US 9,012,420Aptamer for Chymase, and Use Thereof
Lapsed on the fee record
Ended Apr 21, 2019 · High confidence
Lapsed on the fee recordEnded Apr 21, 2019High confidence
US 8,772,259Aptamer to FGF2 and use thereof
Lapsed on the fee record
Ended Jul 8, 2018 · From the USPTO record
Lapsed on the fee recordEnded Jul 8, 2018From the USPTO record
US 8,716,230Methods for Treatment or Prevention of Diseases Associated with Functional Disorder of Regulatory T Cells
Formerly held
Lapsed on the fee record
Ended May 6, 2018 · Medium confidence
Lapsed on the fee recordEnded May 6, 2018Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited